Skip to main content
KARD
NASDAQ Life Sciences

Kardigan Shares Rise 1.6% in Nasdaq Debut After Upsized $400M IPO

Tom Rudovsky · Reported by Reuters
More coverage: Healthcare
Sentiment info
Positive
Importance info
8
Price
$17.72
Mkt Cap
--
52W Low
--
52W High
--
52W Position
Off High
Rel. Volume
Market data snapshot near publication time

Summary

Kardigan's shares rose 1.6% in their Nasdaq debut, following an upsized $400 million initial public offering. This provides the immediate market reaction to the IPO, which was previously announced as priced and successfully raised earlier today. The positive debut performance indicates strong initial investor interest in the heart drug developer.

At the time of this announcement, KARD was trading at $17.72 on NASDAQ in the Life Sciences sector. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

KARD - Latest Insights

KARD
Nov 12, 2026, 7:02 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $15.68
Real-time Price: $13.82 info
Change: -$1.86 (-12%) info
Market Cap: $1.294B info
KARD
Nov 06, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $15.93
Real-time Price: $13.82 info
Change: -$2.11 (-13%) info
Market Cap: $1.294B info
KARD
Nov 06, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $15.52
Real-time Price: $13.82 info
Change: -$1.70 (-11%) info
Market Cap: $1.294B info
KARD
Aug 11, 2026, 7:10 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $20.41
Real-time Price: $13.82 info
Change: -$6.59 (-32%) info
Market Cap: $1.294B info
KARD
Aug 11, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $20.41
Real-time Price: $13.82 info
Change: -$6.59 (-32%) info
Market Cap: $1.294B info